|
|
|
|
|
|
|
|
Cell culture media optimization is a necessary but complex process. Controlling Critical Material Attributes (CMAs) of raw materials can mean the difference between meeting production demand and expensive batch failures. Nu-Tek BioSciences provides biopharmaceutical leaders with a secure, sustainable supply of 100% animal-free raw materials, as well access to our industry-leading Variability Reduction Program. We optimize CMAs specific to customer needs. Contact our team to put our VRP and products to work for you.
|
|
|
|
|
|
|
|
By PharmaSource
|
112 pages of executive insight from CDMO Live Europe 2026: tariffs, geopolitics, supply resilience, AI in manufacturing, and why strategic partnerships remain aspirational for most.
|
|
|
|
|
|
|
|
Visual Inspection
|
|
Article | medac CDMO
|
Automated optical inspection enhances injectable quality by improving detection accuracy, ensuring consistency, and enabling high-speed defect and container integrity checks.
|
|
|
|
|
|
|
|
Where Formulation Expertise Connects
|
|
Article | Coriolis Pharma
|
As pipelines grow more complex and timelines become more ambitious, companies increasingly rely on strong external partners to advance their drug products efficiently and with reduced risk.
|
|
|
|
|
|
LVV Lot Release Testing
|
|
Poster | Minaris
|
Lentiviral vector therapies present distinct testing challenges. Accessing structured release testing panels ensures rigorous safety, reliable lot disposition, and regulatory compliance.
|
|
|
|
|
|
Could Your Expression Host Be The Problem?
|
|
Q&A | 53Biologics
|
Early host selection shapes biological activity, manufacturing costs, and commercial flexibility. Evaluating trade-offs early prevents costly redevelopment and optimizes downstream purification.
|
|
|
|
|
|
When Unexpected Particles Threaten Your Biologic
|
|
Webinar | KBI Biopharma
|
Particle contamination risks biologic safety. Advanced tools like Raman and SEM-EDS identify root causes fast to support robust, regulator-ready strategies that protect product quality.
|
|
|
|
|
|
Engineering Precision In Genetic Medicines
|
|
Webinar | ElevateBio
|
Precision genome editing strategies that balance specificity and potency through advanced engineering workflows, AI‑driven optimization, and tailored editor design for clinical genetic medicines.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Webinar: IND in as Little as 6 Months: Now Beyond mAbs
|
Accelerating biologics development doesn’t have to mean compromising quality or scalability. Join Lonza to explore expanded DNA-to-IND pathways for mAbs, bispecifics, Fc-fusions and high-concentration biologics. Through data, case studies and practical insights, discover how expression technologies, integrated CMC strategies and streamlined execution can reduce timelines, support IND readiness and enable efficient development from early stages through future milestones. Click here to learn more.
|
|
|
| Connect With Bioprocess Online: |
|
|
|
|
